Morgan Stanley Sonoma Pharmaceuticals, Inc. Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	SELL	$2.65 - $4.12 $31 - $49	-12 Reduced 12.24%	86 $0
Q2 2022 Aug 15, 2022	SELL	$2.65 - $4.12 $31 - $49	-12 Reduced 12.24%	86 $0
Q1 2022 Oct 27, 2022	BUY	$2.65 - $4.84 $31 - $58	12 Added 13.95%	98 $0
Q1 2022 May 13, 2022	SELL	$2.65 - $4.84 $6,481 - $11,838	-2,446 Reduced 96.15%	98 $0
Q4 2021 Feb 14, 2022	BUY	$4.32 - $6.27 $10,601 - $15,386	2,454 Added 2726.67%	2,544 $11,000
Q3 2021 Nov 15, 2021	BUY	$5.23 - $8.89 $470 - $800	90 New	90 $0

2.27K

Ticker SNOA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,100,940
Market Cap $8.87M
Description
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.